Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
TRI GLIBEN FORTE  G
TRI GLIBEN FORTE  G
COD not available
DIABETIC RANGE by TRI GLIBEN FORTE

TRI GLIBEN FORTE

INR 51.8 INR 74
You Save: INR 22.2 (30%)

Description

Product details

TRI GLIBEN FORTE Glibenclamide (5mg), Metformin HCI (500mg), Pioglitazone (15mg) TRI GLIBEN FORTE is a combination medication containing Glibenclamide, Metformin HCI, and Pioglitazone. This combination is commonly prescribed for the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production. Glibenclamide (5mg): Glibenclamide belongs to the sulfonylurea class of medications. It works by stimulating the pancreas to release insulin, thereby lowering blood sugar levels. Glibenclamide also helps the body use insulin more effectively. Metformin HCI (500mg): Metformin is a biguanide medication that reduces glucose production in the liver, decreases intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. It is a first-line treatment for type 2 diabetes and helps improve overall glycemic control. Pioglitazone (15mg): Pioglitazone is a thiazolidinedione medication that improves insulin sensitivity in muscle and adipose (fat) tissues. It reduces glucose production in the liver and enhances glucose uptake in peripheral tissues, leading to better blood sugar control. Key Benefits of TRI GLIBEN FORTE: Comprehensive Glucose Control: The combination of Glibenclamide, Metformin HCI, and Pioglitazone targets multiple pathways involved in glucose metabolism, providing comprehensive control over blood sugar levels. Stimulates Insulin Release: Glibenclamide stimulates insulin secretion from the pancreas, especially after meals, helping to regulate postprandial (after-meal) glucose spikes. Improves Insulin Sensitivity: Metformin and Pioglitazone improve insulin sensitivity in cells, allowing for better utilization of glucose and reducing insulin resistance. Reduces Hepatic Glucose Production: Metformin and Pioglitazone both reduce the production of glucose in the liver, helping to lower fasting blood sugar levels. Cardiometabolic Benefits: Pioglitazone may have additional benefits for cardiovascular health, such as reducing inflammation and improving lipid profiles. Dosage and Administration: The typical dosage of TRI GLIBEN FORTE is one tablet taken orally once or twice daily, as prescribed by your healthcare provider. It is usually taken with meals to reduce the risk of gastrointestinal side effects. Follow your doctor's instructions regarding dosage adjustments based on your blood sugar levels and response to treatment. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order Now https://www.sterisonline.com/product/tri-gliben-forte-133450

  • Filter tags

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us